(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to cash-paying U.S. patients at a discount to its listed price as ...

BMS and Pfizer have established a direct-to-patient online program, Eliquis 360 Support, which offers the blood thinner at a discount price.

A 30-day supply of Eliquis currently has a list price of $606, but would cost $346 per month under the new program, according to a report from the Wall Street Journal. Since its approval in 2012 ...

Starting September 8, eligible patients can buy Eliquis through the Eliquis 360 Support program for $346 per month, a 43% discount from its current list price of about $606.

Bristol Myers Squibb and Pfizer said they will start selling their blockbuster blood thinner, Eliquis, directly to some patients at a more than 40% discount. The companies' new effort would bypass ...

Eliquis will be sold directly to U.S. patients for $346/month—over 40% less than its $606 list price. Starting Sept. 8, eligible patients can order Eliquis online with nationwide shipping via ...

Since its launch, Eliquis has been prescribed to over 15 million Americans and in 2024 it generated about $11.4 billion in global revenue.